Results 101 to 110 of about 48,951 (267)

Factors determining short- and long-term survival after orthotopic liver homotransplantation in the dog [PDF]

, 1965
Without azathioprine therapy, the operative risk with orthotopic liver transplantation is small. Twenty-two of 23 animals survived 2 days or more, and 19 for 6 days or longer. All eventually died of rejection within 10 days.
Faris, TD, Herrmann, TJ, Hlad, CJ, Marchioro, TL, Porter, KA, Starzl, TE, Taylor, PD, Waddell, WR   +7 more
core  

Treatment of splenic artery aneurysms of patients with cirrhosis in the Waiting list

Трансплантология (Москва)
Objective. The aim of our work was to evaluate the immediate and remote results of ligation of splenic artery aneurysm in orthotopic liver transplantation in patients with decompensated liver cirrhosis.Material and methods.
Z. A. Bagateliya, P. A. Drozdov, S. A. Astapovich, E. A. Lidzhieva, F. F. Alieva, A. V. Shabunin   +5 more
doaj   +1 more source

CENTRAL PONTINE MYELINOLYSIS AFTER ORTHOTOPIC LIVER TRANSPLANTATION (TWO CASE REPORTS)

Вестник трансплантологии и искусственных органов, 2013
Central pontine myelinolysis (CPM) is the rare, but extremely severe complication after orthotopic liver trans- plantation. The reason for CPM is currently not precisely defined.
A. M. Dzyadzko, M. L. Katin, O. O. Rummo, A. E. Shcherba, E. O. Santotsky, A. F. Minov, M. Y. Gurova, O. A. Chugunova, Y. V. Slobodin, S. M. Zubritsky, L. L. Avdei   +10 more
doaj   +1 more source

Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation [PDF]

, 1998
Background: Because of the rarity of hilar cholangiocarcinoma, its prognostic risk factors have not been sufficiently analyzed. This retrospective study was undertaken to evaluate various pathologic risk factors which influenced survival after curative ...
Dvorchik, I, Fung, JJ, Iwatsuki, S, Lee, RG, Madariaga, JR, Marsh, JW, Starzl, TE, Todo, S   +7 more
core   +1 more source

Prediction of New Onset Diabetes after Liver Transplant [PDF]

arXiv, 2018
25% of people who received a liver transplant will go on to develop diabetes within the next 5 years. These thousands of individuals are at 2-fold higher risk of cardiovascular events, graft loss, infections, as well as lower long-term survival.
arxiv  

Predicting Long-Term Allograft Survival in Liver Transplant Recipients [PDF]

arXiv
Liver allograft failure occurs in approximately 20% of liver transplant recipients within five years post-transplant, leading to mortality or the need for retransplantation. Providing an accurate and interpretable model for individualized risk estimation of graft failure is essential for improving post-transplant care.
arxiv  

Orthotopic liver transplantation for acute and subacute hepatic failure in adults [PDF]

, 1987
Rene Peleman, Judith S. Gavaler, David H. Van Thiel, Carlos O. Esquivel, Robert D. Gordon, Shunzaburo Iwatsuki, Thomas E. Starzl   +6 more
openalex   +1 more source

Interferon-gamma inducible protein 10 (IP10) induced cisplatin resistance of HCC after liver transplantation through ER stress signaling pathway. [PDF]

, 2015
Tumor recurrence remains an obstacle after liver surgery, especially in living donor liver transplantation (LDLT) for patients with hepatocellular carcinoma (HCC).
Geng, Wei, Li, Chang-Xian, Ling, Chang-Chun, Liu, Xiao-Bing, Lo, Chung-Mau, Ma, Yuen-Yuen, Man, Kwan, Ng, Kevin TP, Qi, Xiang, Zhai, Yuan   +9 more
core   +1 more source

Advantages of Venous Bypass During Orthotopic Transplantation of the Liver [PDF]

, 1985
Byers W. Shaw, Douglas Martin, José Marquez, Yeon Soo Kang, ALAN C. BUGBEE, Shunzaburo Iwatsuki, Bartley P. Griffith, Robert Hardesty, Henry T. Bahnson, Thomas E. Starzl   +9 more
openalex   +1 more source

End-Stage Liver Disease Comorbidities in Patients Awaiting Transplantation: Identification and Impact on Liver Transplant Survival [PDF]

arXiv
End-Stage Liver Disease (ESLD), a complex condition, has high rates of co-occurring comorbidities affecting multiple organ systems. There is no clear evidence-based practice (EBP) guidelines addressing the progression of comorbidities in ESLD patients awaiting liver transplantation (LT) and their impact on survival, both pre- and post-transplant.
arxiv